Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
- PMID: 28596677
- PMCID: PMC5442077
- DOI: 10.3748/wjg.v23.i19.3407
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. Its pathogenesis is complex and not yet fully understood. Over the years many studies have proposed various pathophysiological hypotheses, among which the currently most widely accepted is the "multiple parallel hits" theory. According to this model, lipid accumulation in the hepatocytes and insulin resistance increase the vulnerability of the liver to many factors that act in a coordinated and cooperative manner to promote hepatic injury, inflammation and fibrosis. Among these factors, adipose tissue dysfunction and subsequent chronic low grade inflammation play a crucial role. Recent studies have shown that vitamin D exerts an immune-regulating action on adipose tissue, and the growing wealth of epidemiological data is demonstrating that hypovitaminosis D is associated with both obesity and NAFLD. Furthermore, given the strong association between these conditions, current findings suggest that vitamin D may be involved in the relationship between adipose tissue dysfunction and NAFLD. The purpose of this review is to provide an overview of recent advances in the pathogenesis of NAFLD in relation to adipose tissue dysfunction, and in the pathophysiology linking vitamin D deficiency with NAFLD and adiposity, together with an overview of the evidence available on the clinical utility of vitamin D supplementation in cases of NAFLD.
Keywords: Adipokines; Adipose tissue dysfunction; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Obesity; Steatosis; Vitamin D.
Conflict of interest statement
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Figures

Similar articles
-
Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update.Nutrients. 2020 Oct 28;12(11):3302. doi: 10.3390/nu12113302. Nutrients. 2020. PMID: 33126575 Free PMC article. Review.
-
Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.Cells. 2021 Nov 25;10(12):3300. doi: 10.3390/cells10123300. Cells. 2021. PMID: 34943809 Free PMC article. Review.
-
Vitamin D: a new player in non-alcoholic fatty liver disease?World J Gastroenterol. 2015 Feb 14;21(6):1718-27. doi: 10.3748/wjg.v21.i6.1718. World J Gastroenterol. 2015. PMID: 25684936 Free PMC article. Review.
-
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis.J Hepatol. 2015 Feb;62(2):405-11. doi: 10.1016/j.jhep.2014.08.040. Epub 2014 Sep 6. J Hepatol. 2015. PMID: 25195551
-
A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease.Diabetes Metab Syndr. 2019 May-Jun;13(3):2260-2265. doi: 10.1016/j.dsx.2019.05.013. Epub 2019 May 22. Diabetes Metab Syndr. 2019. PMID: 31235166 Review.
Cited by
-
The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.Antioxidants (Basel). 2024 Jun 29;13(7):797. doi: 10.3390/antiox13070797. Antioxidants (Basel). 2024. PMID: 39061866 Free PMC article. Review.
-
Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes.J Clin Med. 2021 Apr 15;10(8):1695. doi: 10.3390/jcm10081695. J Clin Med. 2021. PMID: 33920792 Free PMC article.
-
Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults.Sci Rep. 2024 Jan 22;14(1):1851. doi: 10.1038/s41598-024-52077-5. Sci Rep. 2024. PMID: 38253816 Free PMC article.
-
Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.Nutr Metab Insights. 2019 May 13;12:1178638819847480. doi: 10.1177/1178638819847480. eCollection 2019. Nutr Metab Insights. 2019. PMID: 31308686 Free PMC article.
-
Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.Nutr Metab (Lond). 2018 Feb 9;15:13. doi: 10.1186/s12986-018-0251-5. eCollection 2018. Nutr Metab (Lond). 2018. PMID: 29449867 Free PMC article. Review.
References
-
- Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology. 2007;46:582–589. - PubMed
-
- Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology. 2011;54:1208–1216. - PMC - PubMed
-
- Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972–1978. - PubMed
-
- Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–462. - PubMed
-
- Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002;17 Suppl:S186–S190. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical